NCT05785741 2026-04-06A Study of DB-1310 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting1,000 enrolled
NCT02955940 2025-12-17An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibIncyte CorporationPhase 2 Active not recruiting10 enrolled
NCT03997968 2024-12-24A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsCyteir Therapeutics, Inc.Phase 1/2 Completed169 enrolled
NCT02892123 2024-11-27Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersJazz PharmaceuticalsPhase 1 Completed279 enrolled
NCT05091528 2022-08-18A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive CancersSilverback TherapeuticsPhase 1/2 Terminated2 enrolled 9 charts
NCT00732810 2015-08-05SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)Merck Sharp & Dohme LLCPhase 2 Completed97 enrolled
NCT00010023 2011-04-05Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsNYU Langone HealthPhase 1 Completed